{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:58Z","timestamp":1761100738409},"reference-count":79,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T00:00:00Z","timestamp":1100476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The evolution of combination chemotherapy regimens, combined with improvements in supportive care, has incrementally improved survival outcomes for patients with non\u2010Hodgkin's lymphomas (NHL). Although 40\u201360% of younger patients with diffuse large cell lymphoma can now expect to be cured, significant numbers will either fail to achieve a remission or relapse after attaining a remission. In addition, certain histological subtypes are associated with particularly poor prognoses with combination chemotherapy alone (e.g. mantle cell lymphoma, B\u2010cell prolymphocytic leukaemia). Relatively few of these patients can achieve long\u2010term responses. Other NHL subtypes, whilst associated with more favourable prognoses in terms of overall survival, are rarely, if ever, cured (e.g. most low grade NHL including follicular lymphoma, chronic lymphocytic leukaemia and small lymphocytic lymphoma). For these reasons dose escalation and allogeneic transplantation have been investigated as potential ways of improving outcome, although this has mainly been in the setting of advanced disease. Any possible benefits have frequently been out\u2010weighed by procedural morbidity and mortality. The parallel development of transplantation approaches that limit procedural toxicity along with advances in supportive care require that the role of allogeneic haematopoietic stem cell transplantation in the management of lymphoma be re\u2010evaluated.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05251.x","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T19:48:21Z","timestamp":1103917701000},"page":"153-168","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The role of allogeneic transplantation in non\u2010Hodgkin's lymphoma"],"prefix":"10.1111","volume":"128","author":[{"given":"Karl S.","family":"Peggs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Mackinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Linch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,11,15]]},"reference":[{"key":"e_1_2_35_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701044"},{"key":"e_1_2_35_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1675"},{"key":"e_1_2_35_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701587"},{"key":"e_1_2_35_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402272"},{"key":"e_1_2_35_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89488-0"},{"key":"e_1_2_35_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700781"},{"key":"e_1_2_35_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1205"},{"key":"e_1_2_35_9_1","doi-asserted-by":"publisher","DOI":"10.1054\/blre.1999.0125"},{"key":"e_1_2_35_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.054"},{"key":"e_1_2_35_11_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008202808144"},{"key":"e_1_2_35_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.088"},{"key":"e_1_2_35_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.23.3918"},{"key":"e_1_2_35_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1690"},{"key":"e_1_2_35_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.433"},{"key":"e_1_2_35_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1816.x"},{"key":"e_1_2_35_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.75"},{"key":"e_1_2_35_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.050"},{"key":"e_1_2_35_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01666.x"},{"key":"e_1_2_35_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703548"},{"key":"e_1_2_35_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402905"},{"key":"e_1_2_35_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1549"},{"key":"e_1_2_35_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703788"},{"key":"e_1_2_35_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1406"},{"key":"e_1_2_35_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703573"},{"key":"e_1_2_35_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333"},{"key":"e_1_2_35_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02726.x"},{"key":"e_1_2_35_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701540"},{"key":"e_1_2_35_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1131"},{"key":"e_1_2_35_30_1","first-page":"522a","article-title":"Hematopoietic stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL)","volume":"96","author":"Horowitz M.M.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_35_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200403000-00004"},{"key":"e_1_2_35_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.3.649.649"},{"key":"e_1_2_35_33_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008380527502"},{"key":"e_1_2_35_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3595"},{"key":"e_1_2_35_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/146532402320219736"},{"key":"e_1_2_35_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.501"},{"key":"e_1_2_35_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2003.09.021"},{"key":"e_1_2_35_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704435"},{"key":"e_1_2_35_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000196"},{"key":"e_1_2_35_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1483"},{"key":"e_1_2_35_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00539.x"},{"key":"e_1_2_35_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704290"},{"key":"e_1_2_35_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2275"},{"key":"e_1_2_35_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0506"},{"key":"e_1_2_35_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3390"},{"key":"e_1_2_35_46_1","first-page":"895a","article-title":"Analysis of prognostic factors on the outcome of autologous and allogeneic stem cell transplantations (SCT) for chronic lymphocytic leukemia (CLL)","volume":"98","author":"Michallet M.","year":"2001","journal-title":"Blood"},{"key":"e_1_2_35_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701400"},{"key":"e_1_2_35_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1105"},{"key":"e_1_2_35_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702392"},{"key":"e_1_2_35_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703888"},{"key":"e_1_2_35_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702237"},{"key":"e_1_2_35_52_1","first-page":"4a","article-title":"HLA\u2010matched unrelated donor (MUD) bone marrow transplantation for B\u2010cell chronic lymphocytic leukemia (Results from the CLL Working Group, National Marrow Donor Program)","volume":"19","author":"Pavletic S.","year":"2000","journal-title":"Proceedings of the American Society of Oncology"},{"key":"e_1_2_35_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1513"},{"key":"e_1_2_35_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703891"},{"key":"e_1_2_35_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0701"},{"key":"e_1_2_35_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"e_1_2_35_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1050.1050"},{"key":"e_1_2_35_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1744"},{"key":"e_1_2_35_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4321"},{"key":"e_1_2_35_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-11-0107"},{"key":"e_1_2_35_61_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02295.x"},{"key":"e_1_2_35_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.17.3766"},{"key":"e_1_2_35_63_1","first-page":"669","article-title":"Graft\u2010versus\u2010leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia","volume":"18","author":"Rondon G.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_35_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.12.011"},{"key":"e_1_2_35_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704384"},{"key":"e_1_2_35_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702625"},{"key":"e_1_2_35_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.023"},{"key":"e_1_2_35_68_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509059650"},{"key":"e_1_2_35_69_1","first-page":"17a","article-title":"High dose therapy with allogeneic or autologous stem cell transplantation for relapsed mantle cell lymphoma: the Seattle experience","volume":"17","author":"Sohn S.K.","year":"1998","journal-title":"Proceedings of the American Society of Oncology"},{"key":"e_1_2_35_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701271"},{"key":"e_1_2_35_71_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04203.x"},{"key":"e_1_2_35_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3842"},{"issue":"1","key":"e_1_2_35_73_1","first-page":"672a","article-title":"Durable progression free survival (PFS) following non\u2010myeloablative bone marrow transplantation (BMT) for chemorefractory diffuse large B cell lymphoma (B\u2010LCL)","volume":"98","author":"Spitzer T.R.","year":"2001","journal-title":"Blood"},{"key":"e_1_2_35_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702191"},{"key":"e_1_2_35_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.5.809"},{"key":"e_1_2_35_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11238"},{"key":"e_1_2_35_77_1","first-page":"482a","article-title":"Does transplantation improve outcome in mantle cell lymphoma (MCL)?: a study from the EBMT","volume":"96","author":"Vandenberghe E.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_35_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.10.4201"},{"key":"e_1_2_35_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.8.2142.2142"},{"key":"e_1_2_35_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.9.2454"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05251.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05251.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:33:52Z","timestamp":1697423632000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05251.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,15]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05251.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05251.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,15]]},"assertion":[{"value":"2004-11-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}